Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (211-220 of 236) with videos related to

Pageof 24
Sort By:
European Heart Journal|October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosisCarlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 13, 2020
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) studyDomenico D'Amario, Mattia Galli, Francesco Canonico, et al.
Cardiology Journal|August 1, 2022
Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trialEliano P Navarese, Przemysław Podhajski, Felicita Andreotti, et al.
European Journal of Preventive Cardiology|December 4, 2025
ESC Quality Indicators for Post-myocardial infarction Care: Transition and Chronic Coronary Syndrome Phases. Developed in collaboration with the European Association of Preventive Cardiology of the ESCBaris Gencer, Cedric Follonier, Amr Abdelrahman, et al.
European Heart Journal|July 1, 2011
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of CardiologyPhilippe Gabriel Steg, Kurt Huber, Felicita Andreotti, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Journal of the American College of Cardiology|February 7, 2025
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized TrialsSina Rashedi, Mohammad Keykhaei, Alyssa Sato, et al.
JACC. Cardiovascular Interventions|June 11, 2021
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVREliano Pio Navarese, Zhongheng Zhang, Jacek Kubica, et al.
European Cardiology|June 17, 2021
Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk ManagementDaniel Tt Chong, Felicita Andreotti, Peter Verhamme, et al.
European Heart Journal|October 30, 2016
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on ThrombosisSigrun Halvorsen, Robert F Storey, Bianca Rocca, et al.
Pageof 24

Showing results (211-220 of 236) with videos related to

Sort By:
Pageof 24
European Heart Journal|October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosisCarlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|November 13, 2020
ORal anticoagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the (ORIGAMI) studyDomenico D'Amario, Mattia Galli, Francesco Canonico, et al.
Cardiology Journal|August 1, 2022
Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trialEliano P Navarese, Przemysław Podhajski, Felicita Andreotti, et al.
European Journal of Preventive Cardiology|December 4, 2025
ESC Quality Indicators for Post-myocardial infarction Care: Transition and Chronic Coronary Syndrome Phases. Developed in collaboration with the European Association of Preventive Cardiology of the ESCBaris Gencer, Cedric Follonier, Amr Abdelrahman, et al.
European Heart Journal|July 1, 2011
Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of CardiologyPhilippe Gabriel Steg, Kurt Huber, Felicita Andreotti, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Journal of the American College of Cardiology|February 7, 2025
Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized TrialsSina Rashedi, Mohammad Keykhaei, Alyssa Sato, et al.
JACC. Cardiovascular Interventions|June 11, 2021
Development and Validation of a Practical Model to Identify Patients at Risk of Bleeding After TAVREliano Pio Navarese, Zhongheng Zhang, Jacek Kubica, et al.
European Cardiology|June 17, 2021
Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk ManagementDaniel Tt Chong, Felicita Andreotti, Peter Verhamme, et al.
European Heart Journal|October 30, 2016
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on ThrombosisSigrun Halvorsen, Robert F Storey, Bianca Rocca, et al.
Pageof 24